Please select the market sector you are interested in.
Please select the university you are interested in.
Show only Easy Access opportunities.
Narrow your search with a few keywords.
Sign up to our technology alerts and be the first to hear about any new technology opportunities from Scotland's universities
Certain types of university intellectual property can sometimes prove difficult to commercialise through traditional routes, usually because it is at an early stage of development, or because it presents enough uncertainty for companies to risk an investment.
University Technology’s Easy Access portal offers access to this type of intellectual property at no cost, to enable companies to evaluate it and put it to use quickly, with reduced risk.
Easy Access uses quick and simple licence agreements to fast-track the transfer of knowledge and expertise from Scotland’s universities to industry, so that these technologies may be developed for the benefit of the economy and society.
Through this initiative, our aim is to make it easier for Scottish universities and industry to work together and build strong, long-term relationships with industry partners
Showing 21 - 30 of 79 opportunities
New methods for cleaning surgical instruments that completely remove protein contamination, including prions – the infectious agents that cause Creutzfeldt-Jakob Disease (CJD) in humans.
For decades, a simple and convenient way of enabling people with diabetes to monitor their own blood sugar levels has eluded medical science. Advances in nanometrology – measuring at the nanoscale – are bringing the prospect within reach with ‘smart’ tattoos.
Water content in Oil and condition monitoring are critical to Hydrocarbon processing and transfer. Having proven the concept, HWU is developing technology to meet this need and now seeks Industry partners for research collaborations & co-development of a new range of solid state sensors for pipeline...
The timely diagnosis and precise identification of infectious agents remains an ever-present challenge for healthcare and biosecurity professionals. Detection of such agents is often possible through a range of assays including culture-based tests and immunoassays...
We have developed a new, highly efficient method of synthesising DNA-binding polyamides - small molecules that can be designed to target virtually any pre-determined DNA sequence and offer a potentially generic approach for the regulation of gene expression.
Lung cancer is the most common cancer in the world and is the leading cause of cancer death. Cisplatin is poorly absorbed orally and only 0.1% of the dose reaches the lungs after intravenous administration, where it has a short residence time. Cisplatin has poor solubility and renal toxicity ...
Natural products are perceived to be too difficult to use in the ultra-high throughput screening approach preferred by pharmaceutical companies. We have developed a method which allows high throughput screening of anticancer agents directly on cells from samples of ovarian tumours from patients...
Drug-eluting stents (DES) have significantly reduced rates of restenosis compared to their bare metal counterparts and are now increasingly the treatment of choice for percutaneous coronary revascularisations. Despite this, they are not suitable for all cases and anti-platelet therapy can still be r...
Adherent glioma neural stem (GNS) cell lines that retain the characteristics of the original tumour-initiating cells, delivering a powerful model system for chemical and genetic screening.
Researchers at the University of Dundee have developed a novel, ultrasonic actuated needle with the potential to improve the efficacy and efficiency of all needle-assisted percutaneous procedures.